Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
84.3 EUR | +1.93% | +6.10% | +40.03% |
04-02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
03-12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
MarketScreener Editorial Features
Global markets live: Macy's, Salesforce, Dollar General, Nordstrom, Exxon... | June 01, 2023 at 04:48 pm | |
Alert: New entry in the European portfolio | August 30, 2021 at 10:57 am |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- MarketScreener Editorial Features